Introduction
============

A cataract is the manifestation of ocular lens opacification \[[@r1]-[@r3]\]. The principal function of the lens is to transmit light and focus it on the retina. Then the retina transforms the light into visual signals \[[@r4],[@r5]\]. The transparency of the lens stems from the complete loss of organelles during the differentiation of lens fiber cells \[[@r6]\]. Cataracts are classified according to their morphology and the location of the opacity in the lens \[[@r7]\]. Congenital cataract (CC) is the primary cause of visual impairment in children worldwide \[[@r8]\]. The prevalence of isolated CC in industrialized countries is estimated at 1--6/10,000 live births \[[@r9]-[@r11]\], whereas these numbers are estimated to be 5--15/10,000 in developing countries \[[@r12]\]. Cataracts contribute nearly 39.1% of total blindness globally; however, the proportion is considerably higher (51.5%) in Pakistan. Congenital cataracts account for 23.0% of the total 54.7% visually handicapped children in Pakistan \[[@r13],[@r14]\].

To date, 32 genes and loci have been implicated in non-syndromic autosomal recessive CC (arCC). Causative mutations in *EPHA2* (Gene ID 1969, OMIM [176946](https://www.ncbi.nlm.nih.gov/omim/?term=176946)), *GJA8* (Gene ID 2703, OMIM [600897](https://www.ncbi.nlm.nih.gov/omim/?term=600897)), *FOXE3* (Gene ID 2301, OMIM [601094](https://www.ncbi.nlm.nih.gov/omim/?term=601094)), *FYCO1* (Gene ID 79443, OMIM [607182](https://www.ncbi.nlm.nih.gov/omim/?term=607182)), *GCNT2* (Gene ID 2651, OMIM [600429](https://www.ncbi.nlm.nih.gov/omim/?term=600429)), *AGK* (Gene ID 55750, OMIM [610345](https://www.ncbi.nlm.nih.gov/omim/?term=610345)), *AKR1E2* (Gene ID 83592, OMIM [617451](https://www.ncbi.nlm.nih.gov/omim/?term=617451)), *RNLS* (Gene ID 55328, OMIM [609360](https://www.ncbi.nlm.nih.gov/omim/?term=609360)), *DNMBP* (Gene ID 23268, OMIM [611282](https://www.ncbi.nlm.nih.gov/omim/?term=611282)), *CRYAB* (Gene ID 1410, OMIM [123590](https://www.ncbi.nlm.nih.gov/omim/?term=123590)), *MIP* (Gene ID 4284, OMIM [154050](https://www.ncbi.nlm.nih.gov/omim/?term=154050)), *GJA3* (Gene ID 2700, OMIM [121015](https://www.ncbi.nlm.nih.gov/omim/?term=121015)), *HSF4* (Gene ID 3299, OMIM [602438](https://www.ncbi.nlm.nih.gov/omim/?term=602438)), *LONP1* (Gene ID 9361, OMIM [605490](https://www.ncbi.nlm.nih.gov/omim/?term=605490)), *WDR87* (Gene ID 83889), *SIPA1L3* (Gene ID 23094, OMIM [616655](https://www.ncbi.nlm.nih.gov/omim/?term=616655)*), LIM2* (Gene ID 3982, OMIM, [154045](https://www.ncbi.nlm.nih.gov/omim/?term=154045)), *BFSP1* (Gene ID 631, OMIM [603307](https://www.ncbi.nlm.nih.gov/omim/?term=603307)), *BFSP2* (Gene ID 8419, OMIM [603212](https://www.ncbi.nlm.nih.gov/omim/?term=603212)), *CRYAA* (Gene ID 1409, OMIM [123580](https://www.ncbi.nlm.nih.gov/omim/?term=123580)), *CRYBA1* (Gene ID 1411, OMIM [123610](https://www.ncbi.nlm.nih.gov/omim/?term=123610)), *LSS* (Gene ID 4047, OMIM [600909](https://www.ncbi.nlm.nih.gov/omim/?term=600909)), *CRYBB3* (Gene ID 1417, OMIM [123630](https://www.ncbi.nlm.nih.gov/omim/?term=123630)), *CRYBB1* (Gene ID 1414, OMIM [600929](https://www.ncbi.nlm.nih.gov/omim/?term=600929)), *CRYBA4* (Gene ID 1413, OMIM [123631](https://www.ncbi.nlm.nih.gov/omim/?term=123631)), *TDRD7* (Gene ID 23424, OMIM [611258](https://www.ncbi.nlm.nih.gov/omim/?term=611258)), and *GALK1* (Gene ID 2584, OMIM [604313](https://www.ncbi.nlm.nih.gov/omim/?term=604313)) have been implicated in CC \[[@r15]-[@r35]\]. In addition to genes, five loci (3q, 7q, 8p, 9q, and 19q) have been reported for CC \[[@r36]-[@r40]\]. Genetic mutations leading to impaired protein folding and solubility in lens fiber cells account for one-third of the total isolated CC cases \[[@r41]-[@r43]\]. Approximately 50% and 25% of the total mutations causing isolated CC have been reported in genes encoding crystallin and connexin proteins, respectively \[[@r44]\].

FYVE and coiled-coil domain containing 1 (FYCO1), an autophagy adaptor protein, interacts with microtubule-associated protein 1 light chain 3B (MAP1LC3B), phosphatidylinositol-3-phosphate (PI3P), and RAB7. We have previously shown that multiple loss-of-function mutations in *FYCO1* result in arCC \[[@r17]\], and contribute to nearly 14% of the total genetic load of arCC in Pakistani families (16/116) \[[@r18]\]. In this study, we screened 13 other families and identified two novel and a previously reported mutation in *FYCO1* bringing the total genetic contribution of mutations in *FYCO1* responsible for arCC in this cohort to 15% (19/129).

Methods
=======

Ascertainment of families and clinical evaluation
-------------------------------------------------

A large cohort of consanguineous Pakistani families (\>200) with two or more affected individuals with congenital cataracts without any environmental or systemic involvement was recruited in a collaborative study to identify new disease-causing loci for congenital visual disorders. Institutional review boards (IRBs) of the National Centre of Excellence in Molecular Biology (Lahore, Pakistan), the National Eye Institute (Bethesda, MD), and the Johns Hopkins University (Baltimore, MD) granted approval for this study. Informed written consent adhering to the tenets of the Declaration of Helsinki was signed by each participating subject.

Thirteen families with non-syndromic arCC were selected for the present study. Detailed family and medical histories were compiled by reviewing available medical records and interviewing family members. Ophthalmic examination of all the participating subjects was conducted with slit-lamp microscopy at the Layton Rahmatulla Benevolent Trust Hospital (Lahore, Pakistan). Affected and unaffected members of each family donated about 10 ml of a blood sample which was collected in 50 ml Sterilin® Falcon tubes (BD Biosciences, San Jose, CA) that had 400 µl of 0.5 M EDTA. For long-term storage, blood samples were placed at -20 °C. Genomic DNAs were extracted from white blood cells using a organic method as described previously \[[@r23]\]. The concentration of the extracted DNA was estimated using a SmartSpec plus BIO-Rad Spectrophotometer (Bio-Rad, Hercules, CA).

Exclusion analysis
------------------

Short tandem repeat (STR) marker-based exclusion analysis was performed for 19 reported genes and loci previously associated with arCC. They included D1S402, D1S436, D1S2697, D1S1592, D1S2826, and D1S2864 for *EPHA2*; D1S496, D1S186, D1S432, D1S3721, D1S197, D1S2652, and D1S2890 for *FOXE3*; D1S2726, D1S252, D1S498, and D1S2635 for *GJA8*; D3S3527, D3S3685, D3S3582, D3S1767, D3S1581, and D3S1289 for *FYCO1*; D6S1034, D6S1653, and D6S429 for *GCNT2*; D7S2513, D7S661, and D7S636 for *AJK*; D11S2017, D11S1986, and D11S4111 for *CRYAB*; D16S3043, D16S3086, and D16S421 for *HSF4*; D17S1301 and D17S1839 for *GALK1*; D19S246, D19S589, and D19S254 for *LIM2*; D20S852, D20S112, D20S860, and D20S912 for *BFSP1*; D21S1411 and D21S1259 for *CRYAA*; D22S419, D22S1167, and D22S1144 for *CRYBB1*; D22S427, D22S686, D22S1167, D22S1144, and D22S689 for *CRYBB3*; D3S1565, D3S3715, and D3S3609 for chromosome 3q; D7S492, D7S657, D7S2430, D7S2482, D7S515, D7S692, and D7S2554 chromosome 7q; D8S550, D8S552, D8S1827, D8S549, and D8S1734 for chromosome 8p; D9S933, D9S167, D9S776, and D9S1790 for chromosome 9q; and D19S433, D19S416, and D19S220 for chromosome 19q loci.

PCRs with fluorescently labeled primer pairs were performed in a GeneAmp PCR System 2700 thermocycler (Applied Biosystems, Waltham, MA). Concisely, each reaction was completed in 5 μl reaction volume containing 50 ng genomic DNA as template, 0.15 μl of 10 mM dye-labeled primer pair, 0.5 μl of 10X PCR Buffer \[100 mM Tris HCl (pH 8.5), 500 mM KCl, 15 mM MgCl~2~\], 0.5 μl of 10 mM dNTP mix, and 0.2 μl of 5 U/μl *Taq* DNA polymerase. Initial denaturation was performed for 5 min at 95 °C, followed by 35 cycles of 30 s at 94 °C for denaturation, 45 s at 54 °C for annealing, 2 min at 65 °C for extension, and then 10 min at 72 °C for a final extension step. Amplified products from each DNA sample were pooled (up to 20) and mixed with an HD-400 size standards (Applied Biosystems) loading cocktail. The resulting amplicons were resolved in a 3730 DNA Analyzer (Applied Biosystems), and genotypes were assigned with ABI PRISM GeneMapper Software v4.0 (Applied Biosystems).

Linkage analysis
----------------

The [FASTLINK](https://www.ncbi.nlm.nih.gov/CBBresearch/Schaffer/fastlink.html) version of MLINK from the LINKAGE Program Package (provided in the public domain by the Human Genome Mapping Project Resources Centre, Cambridge, UK) was used to perform two-point linkage analyses and to calculate the maximum logarithm of odds (LOD) scores (Z~max~) \[[@r45],[@r46]\]. Autosomal recessive CC was analyzed as a fully penetrant trait with 0.001 affected allele frequency. The order of the markers and the distances between them were obtained from the Marshfield database and the National Center for Biotechnology Information (NCBI, Bethesda, MD) chromosomes sequence maps. Allele frequencies were estimated from 96 unrelated and unaffected individuals from the Punjab province of Pakistan.

Sanger sequencing
-----------------

Primer pairs (forward and reverse) for *FYCO1* were designed using the Primer3 (Ver. 0.4.0). Amplifications were performed in a 25 µl mixture containing 50 ng of genomic DNA, 0.5 µl of each primer (4 µM), 2.5 μl of 10X PCR Buffer \[100 mM Tris HCl (pH 8.5), 500 mM KCl, 15 mM MgCl~2~\], 1.25 μl of 10 mM dNTP mix, and 1 μl of 5 U/μl *Taq* DNA polymerase. PCR amplification of exons covered an initial denaturation step for 5 min at 95 °C followed by a two-step procedure. The first touchdown step of ten cycles consisted of 30 s denaturation at 95 °C, followed by annealing at 68 °C for 30 s (annealing temperature decreased by 1 °C/cycle), and 1-min extension at 72 °C. The second step of 30 cycles consisted of 30 s denaturation at 95 °C, followed by annealing at 58 °C for 30 s (10 °C below the annealing temperature of the first step), 1-min extension at 72 °C, and then a final extension step of 10 min at 72 °C. Amplicons were analyzed on 1.5% agarose gel and purified with 95% ethanol precipitation. The PCR primers for each exon were used for bidirectional Sanger sequencing using BigDye Terminator ready reaction mix (Applied Biosystems) according to the manufacturer's instructions. Sequencing products were precipitated (sodium acetate, EDTA, and ethanol), resuspended in 10 µl of formamide (Applied Biosystems), denatured for 5 min at 95 °C, and resolved on a 3730 DNA Analyzer (Applied Biosystems). Forward and reverse sequencing results were assembled with ABI PRISM® sequencing analysis software (Ver. 3.7) and analyzed with Sequencher software (Gene Codes Corporation, MI).

Prediction analysis
-------------------

Evolutionary conservation of the mutated amino acid in FYCO1 orthologs was examined using the [UCSC Genome Browser](http://genome.ucsc.edu). The possible impact of amino acid substitution on the structure of the FYCO1 protein at the location of the missense mutation was examined with [PolyPhen-2](http://genetics.bwh.harvard.edu/pph), [Mutation Assessor](http://mutationassessor.org), [Mutation Taster](http://www.mutationtaster.org), and [SIFT](http://sift.jcvi.org).

Results
=======

Three consanguineous families (PKCC193, PKCC202, and PKCC220) were recruited from the Punjab province of Pakistan. Pedigree drawings demonstrated an autosomal recessive mode of inheritance ([Figure 1](#f1){ref-type="fig"}). Detailed medical history obtained after interviews with family members, and the patient's available medical records confirmed that cataracts were observed in the first or second year after birth and segregated in an isolated fashion without any other ocular and non-ocular anomalies in affected individuals of three families ([Table 1](#t1){ref-type="table"}).

![Genetic analysis of chromosome 3p21-linked pedigrees harboring mutations in *FYCO1*. **A**: Pedigree illustrating the segregation of a single base substitution (c.4270C\>T; p.Arg1424Ter) in all available affected and unaffected members of PKCC193. **B**: Pedigree illustrating the segregation of a single base deletion (c.3196delC; p.His1066IlefsTer10) in all available affected and unaffected members of PKCC202. **C**: Illustration of a pedigree showing the segregation of a single base change (c.4127T\>C; p.Leu1376Pro) in all available affected and unaffected members of PKCC220. The haplotypes of six 3p21 microsatellite markers are shown. The alleles forming the risk haplotype are in black, and the alleles not cosegregating with cataract are shown in white. Note: Squares: males; circles: females; filled symbols: affected individuals; double line between individuals: consanguinity; diagonal line through a symbol: deceased family member.](mv-v26-334-f1){#f1}

###### Clinical characteristics of families PKCC193, PKCC202, and PKCC220 harboring mutations in *FYCO1*.

  Family ID   Individual ID   Sex   Age at first symptoms \*   Age at enrollment   Visual Acuity (OD/OS)   Clinical Findings
  ----------- --------------- ----- -------------------------- ------------------- ----------------------- ------------------------------
  PKCC193     11              F     2.5 months                 7 years             PL/PL                   B/L cataracts, B/L nystagmus
              12              F     4 months                   1 year              PL/PL                   B/L cataracts, squint
              16              M     11 months                  32 years            CF/CF                   B/L cataracts
              17              M     1.5 years                  36 years            CF/CF                   B/L cataracts, B/L nystagmus
  PKCC202     10              M     4 months                   10 months           CF/CF                   B/L cataracts
              11              F     3 months                   6.5 years           No PL/CF                B/L cataracts
  PKCC220     7               F     5 months                   4 years             CF/CF                   B/L cataracts
              8               F     3 months                   9 months            CF/CF                   B/L cataracts

Abbreviations: CF, counting fingers; PL, light perception; B/L, bilateral; OD, oculus dextrus; OS, oculus sinister. \* The age at first symptoms of cataracts (cloudiness) in affected individuals is according to the family medical records and/or information provided by the family elders.

Linkage analysis localized the disease interval to chromosome 3p harboring *FYCO1* ([Figure 1](#f1){ref-type="fig"}). Interestingly, *FYCO1*, a gene previously implicated in non-syndromic arCC in multiple Pakistani families \[[@r17]\], resides in the linkage interval. A maximum two-point LOD score of 3.06 (θ=0) was obtained with marker D3S3685 in PKCC193 ([Table 2](#t2){ref-type="table"}). A maximum two-point LOD score of 1.68 (θ=0) was obtained with marker D3S3582 in PKCC202 ([Table 2](#t2){ref-type="table"}). A maximum two-point LOD score of 1.34 (θ=0) was obtained with markers D3S3582 and D3S1289 in PKCC220 ([Table 2](#t2){ref-type="table"}).

###### Two-point LOD scores of chromosome 3p microsatellite markers with alleles of families PKCC193, PKCC202, and PKCC220.

  ID        Markers   cM      Mb     0       0.01    0.03    0.05    0.07    0.09    0.1     0.2     0.3     Z**~max~**   θ**~max~**
  --------- --------- ------- ------ ------- ------- ------- ------- ------- ------- ------- ------- ------- ------------ ------------
  PKCC193   D3S3527   63.12   39.3   −1.22   −0.91   −0.15   0       0.19    0.29    0.33    0.21    0.04    0.33         0.1
            D3S3685   67.94   42.5   3.06    3.06    2.99    2.85    2.71    2.57    2.43    2.36    1.67    3.06         0
            D3S3582   69.19   45.4   2.75    2.7     2.58    2.46    2.34    2.21    2.15    1.54    0.91    2.75         0
            D3S1767   69.9    47     1.7     1.64    1.53    1.43    1.33    1.23    1.16    0.63    0.21    1.7          0
            D3S1581   70.61   48.6   2.78    2.73    2.5     2.38    2.26    2.05    1.99    1.22    0.55    2.78         0
            D3S1289   71.41   54.5   1.29    1.25    1.17    1.13    1.05    1.04    0.97    0.65    0.35    1.29         0
  PKCC202   D3S3527   63.12   39.3   0.69    0.68    0.66    0.63    0.61    0.57    0.56    0.38    0.2     0.69         0
            D3S3685   67.94   42.5   0.68    0.66    0.64    0.61    0.58    0.54    0.52    0.35    0.18    0.68         0
            D3S3582   69.19   45.4   1.68    1.63    1.54    1.44    1.34    1.24    1.19    0.72    0.33    1.68         0
            D3S1767   69.9    47     0.16    0.16    0.15    0.15    0.14    0.14    0.13    0.1     0.06    0.16         0
            D3S1581   70.61   48.6   1.63    1.59    1.49    1.39    1.29    1.2     1.15    0.69    0.31    1.63         0
            D3S1289   71.41   54.5   0.68    0.66    0.64    0.61    0.58    0.54    0.52    0.35    0.18    0.68         0
  PKCC220   D3S3527   63.12   39.3   -∞      −1.64   −1.14   −0.90   −0.74   −0.62   −0.57   −0.25   −0.10   −0.10        0.3
            D3S3685   67.94   42.5   1.03    1       0.94    0.89    0.83    0.77    0.74    0.47    0.22    1.03         0
            D3S3582   69.19   45.4   1.34    1.32    1.26    1.2     1.15    1.09    1.06    0.78    0.5     1.34         0
            D3S1767   69.9    47     1.03    1       0.94    0.89    0.83    0.77    0.74    0.47    0.22    1.03         0
            D3S1581   70.61   48.6   0.24    0.23    0.21    0.19    0.18    0.16    0.15    0.08    0.03    0.24         0
            D3S1289   71.41   54.5   1.34    1.32    1.26    1.2     1.15    1.09    1.06    0.78    0.5     1.34         0

Next, we sequenced all coding exons and the exon--intron junctions of *FYCO1* in all three families. We identified a novel homozygous substitution (c.4270C\>T) in PKCC193 ([Figure 2A,B](#f2){ref-type="fig"}). This homozygous substitution results in premature termination of the FYCO1 protein by changing arginine at position 1424 into a stop codon (p.Arg1424Ter; [Figure 2A,B](#f2){ref-type="fig"}). All affected individuals of PKCC193 are homozygous for this variation, whereas unaffected individuals are either heterozygous or homozygous for the wild-type allele ([Figure 1A](#f1){ref-type="fig"}). This variant (c.4270C\>T; p.Arg1424Ter) was identified in the heterozygous state in three different population databases with a global minor allele frequency (MAF) of 0.000008 ([gnomAD](https://gnomad.broadinstitute.org)), 0.000008 ([ExAC](http://exac.broadinstitute.org)), and 0.00002 ([TOPMed](https://www.nhlbi.nih.gov/science/trans-omics-precision-medicine-topmed-program)) in two individuals of non-Finnish European descent, a single African individual, and three individuals of a study-wide group, respectively. We did not find the c.4270C\>T mutation in the Asian population and in 96 ethnically matched control individuals.

![Bidirectional Sanger sequencing identified mutations in *FYCO1* in chromosome 3p21-linked pedigrees. **A**, **B**: Forward and reverse sequence chromatograms of individual 18 (unaffected) harboring the wild-type allele and individual 11 (affected) homozygous for a single base change: c.4270C\>T (p.Arg1424Ter) in PKCC193. **C**, **D**: Forward and reverse sequence chromatograms of individual 7 (unaffected) harboring the wild-type allele and individual 10 (affected) homozygous for a single base deletion: c.3196delC (p.His1066IlefsTer10) in PKCC202. **E**, **F**: Forward and reverse sequence chromatograms of individual 6 (unaffected) heterozygous for a single base change and individual 7 (affected) homozygous for a single base substitution: c.4127T\>C (p.Leu1376Pro) in PKCC220. Note: The arrows point to the base-pair substitution or deletion identified in each pedigree.](mv-v26-334-f2){#f2}

In PKCC202, we identified a novel homozygous single-base deletion (c.3196delC) in *FYCO1* resulting in a frameshift mutation and premature truncation of the protein (p.His1066IlefsTer10; [Figure 2C,D](#f2){ref-type="fig"}). The p.His1066IlefsTer10 variant showed segregation with the disease phenotype in all affected and unaffected individuals of PKCC202 ([Figure 1B](#f1){ref-type="fig"}) and was not identified in the [1000 Genomes](https://www.internationalgenome.org/1000-genomes-browsers/), ExAC browser, [Exome Variant Server](https://evs.gs.washington.edu/EVS/), and [dbSNP](https://www.ncbi.nlm.nih.gov/snp/) databases. Moreover, the variant was also absent in 96 ethnically matched control individuals. In addition to novel variants, we identified a reported missense variant (c.4127T\>C, p.Leu1376Pro) in PKCC220 ([Figure 2E,F](#f2){ref-type="fig"}). The variant revealed complete segregation with the disease phenotype in all available affected and unaffected individuals of PKCC220 ([Figure 1C](#f1){ref-type="fig"}) and was not present in 96 ethnically matched control individuals.

In contrast to the two novel mutations, i.e., the frameshift (c.3196delC; p.His1066IlefsTer10) and nonsense (c.4270C\>T; p.Arg1424Ter) that are predicted to result in truncated FYCO1 proteins, the transcript harboring the previously reported missense (c.4127T\>C, p.Leu1376Pro) allele is expected to produce a full-length FYCO1 protein. Importantly, amino acid leucine 1376 (in FYCO1) and the amino acids in the immediate neighborhood are well conserved in FYCO1 orthologs ([Figure 3](#f3){ref-type="fig"}). We next examined the effect of leucine substitution on the FYCO1 protein with in silico analysis. PolyPhen-2, Mutation Assessor, MutationTaster, and SIFT algorithms were suggestive of probably damaging, low impact, disease-causing, and deleterious, respectively. Taken together, evolutionary conservation and in silico analysis suggest that the proline substitution would be detrimental to the native structure, and most likely, the physiological function of the FYCO1 protein.

![Sequence alignment of FYCO1 orthologs illustrating the conservation of amino acid leucine at position 1376. The boxed amino acids illustrate the conservation of Leu1376 among other FYCO1 orthologs. Red: primates; green: Euarchontoglires; blue: Laurasiatheria; black: Afrotheria.](mv-v26-334-f3){#f3}

Discussion
==========

We report two novel and a previously reported mutation in *FYCO1* associated with non-syndromic autosomal recessive cataracts in three unrelated consanguineous familial cases. The ophthalmic examination confirmed cataracts in all three families. The STR marker-based linkage analysis localized the critical interval to chromosome 3p with maximum two-point LOD scores of 3.06, 1.68, and 1.34 at θ=0 for PKCC193, PKCC202, and PKCC220, respectively ([Table 2](#t2){ref-type="table"}). Sequencing of the coding exons of *FYCO1* identified two novel and a reported mutation that segregated with the disease phenotype in all three families and was absent in control individuals. Taken together, these results strongly suggest that mutations in *FYCO1* are responsible for recessive congenital cataracts in PKCC193, PKCC202, and PKCC220.

FYCO1 is a member of the PI(3)P-binding protein family localized to autophagosomes and mediates transport of microtubule plus-end-directed vesicles \[[@r47]\]. The domain structure of FYCO1 comprises an α-helical RUN domain, four long coiled-coil regions, an FYVE zinc-finger domain, an LC3-interacting region (LIR), and a Golgi dynamics (GOLD) domain \[[@r17],[@r48]\]. Pras et al. first reported a novel locus CATC2 (cataract, autosomal recessive congenital 2, OMIM: [610019](https://www.ncbi.nlm.nih.gov/omim/?term=610019)) mapped in three consanguineous Arab families to the short arm of chromosome 3 \[[@r49]\]. Subsequently, Chen and colleagues mapped additional multiple familial cases with arCC at chromosome 3p overlapping with the CATC2 locus and identified mutations in *FYCO1* in 12 Pakistani and one Arab family \[[@r17]\].

To date, a total of 19 mutations have been reported in *FYCO1,* including 11 mutations in the coiled-coil region of FYCO1 ([Table 3](#t3){ref-type="table"}). In another study, Chen and colleagues reported two homozygous variants (c.2345delA; p.Gln782ArgfsTer32 and c.3151--2A\>C; p.Ala1051AspfsTer27) implicated in arCC in Pakistani families \[[@r18]\]. Recently, multiple studies reported mutations in *FYCO1* implicated in arCC in Saudi (c.2506delG; p.Ala836ProfsTer80 and c.449T\>C; p.Ile150Thr), Egyptian (c.2206C\>T; p.Gln736Ter), and British (c.3670C\>T; p.Arg1224Ter and c.3945--1G\>C) familial and sporadic cases \[[@r34],[@r50]-[@r52]\]. Moreover, two compound heterozygous variants in *FYCO1* have been reported from Saudi Arabia and China \[[@r53],[@r54]\]. Two homozygous mutations in *FYCO1* have also been identified in Iranian and Russian familial cases \[[@r55],[@r56]\].

###### Summary of cataract-causing mutations identified in *FYCO1*.

  Exon/ Intron   DNA Change                          Protein Change              Type                    Population   Reference
  -------------- ----------------------------------- --------------------------- ----------------------- ------------ ------------
  Ex6            c.449T\>C                           p.I150T                     Missense                KSA          34
  Ex8            c.808C\>T and IVS12; c.3587+1G\>T   p.Q270X/ splice variant     Compound heterozygous   China        53
  Ex8            c.1045C\>T                          p.Q349X                     Nonsense                Pakistan     17
  Ex8            c.l056_1071delGGCCACACGGGACTCA      p.E352DfsX9                 Frameshift              Iran         56
  Ex8            c.1546C\>T                          p.Q516X                     Nonsense                Israel       17
  Ex8            c.1621C\>T                          p.Q541X                     Nonsense                Russia       55
  Ex8            c.2206C\>T                          p.Q736X                     Nonsense                Pakistan     17
  Ex8            c.2206C\>T                          p.Q736X                     Nonsense                Egypt        50
  Ex8            c.2206C\>T                          p.Q736X                     Nonsense                Pakistan     18
  Ex8            c.2345delA                          p.Q782RfsX32                Frameshift              Pakistan     18
  Ex8            c.2345delA/ c.2714_2715delCA        p.Q782RfsX32/ p.T905SfsX2   Compound heterozygous   KSA/ UAE     54
  Ex8            c.2506delG                          p.A836PfsX80                Frameshift              KSA          51
  Ex8            c.2761C\>T                          p.R921X                     Nonsense                Pakistan     17
  Ex8            c.2830C\>T                          p.R944X                     Nonsense                Pakistan     17
  IVS9           c.3150+1G\>T                        Splice variant              Splice variant          Pakistan     17
  IVS9           c.3151--2A\>C                       p.A1051DfsX27               Frameshift              Pakistan     18
  Ex10           c.3196delC                          p.H1066IfsX10               Frameshift              Pakistan     This Study
  Ex13           c.3670C\>T                          p.R1224X                    Nonsense                UK           52
  Ex13           c.3755delC                          p.A1252DfsX71               Frameshift              Pakistan     17
  Ex14           c.3858_3862dupGGAAT                 p.L1288WfsX37               Frameshift              Pakistan     17
  IVS14          c.3945--1G\>C                       Splice variant              Splice variant          UK           52
  Ex16           c.4127T\>C                          p.L1376P                    Missense                Pakistan     17
  Ex16           c.4127T\>C                          p.L1376P                    Missense                Pakistan     This Study
  Ex17           c.4270C\>T                          p.R1424X                    Nonsense                Pakistan     This Study

Note: KSA: Kingdom of Saudi Arabia; UAE: United Arab Emirates; UK: United Kingdom.

In conclusion, identification of multiple mutations in *FYCO1* in diverse populations and the higher frequency of frameshift, splice, and nonsense mutations strongly suggest the significant contribution of *FYCO1* in congenital cataracts. Moreover, the identification of mutations responsible for arCC in the present study further highlights the significant genetic contribution in familial cases of Pakistani descent, in general, and this cohort of arCC in particular, nearly 15% (19/129). This investigation will help to devise better strategies for identifying individuals at risk through genetic diagnosis leading to better cataract prevention.
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